GALC
Krabbe Disease: GALC Sequencing
Key Information
Lab:
TAT:
21 days
Price:
$1,000
CPT Code(s):
81406
Test Code:
DGAC
Prenatal Samples Accepted
Krabbe Disease: GALC Sequencing
GALC sequencing is a molecular test used to identify variants in the gene associated with Krabbe disease. This test can also confirm a diagnosis and identify disease-causing variants within a family to facilitate carrier screening.
Krabbe disease
Clinical Information
Krabbe disease leads to the accumulation of galactosylceramide specifically in brain white matter, causing a neurological phenotype. Patients with the severe, infantile form of Krabbe disease will typically present by 3-6 months of age with rapidly progressive neurodegeneration, muscle rigidity, seizures, irritability, vomiting, and blindness and/or deafness. Approximately 10-15% of cases exhibit a milder, late onset clinical phenotype, with patients presenting with general weakness or stiffness, ataxia, vision loss, and some intellectual regression.
Technical Information
Specimen Requirements
Transport Instructions
Prenatal Testing Information
Prenatal diagnosis may be available for familial pathogenic or likely pathogenic variants; full sequencing of the GALC gene is not available. For variants identified at external laboratories, GGC will need to review the variant classification prior to sample receipt.
Prenatal diagnosis is not available for variants of uncertain clinical significance. Additional fees for cell culture and maternal cell contamination may apply. Maternal cell contamination studies are required for all prenatal molecular tests. Contact the laboratory prior to sending a prenatal specimen to confirm that targeted testing can be accepted.
Prenatal Specimen Requirements
Prenatal Transport Instructions
Connect With Our Experts
Call 1-800-473-9411 to speak with our team of laboratory genetic counselors for questions or additional information.
Robin Fletcher, MS, CGC
Falecia Thomas, MS, CGC
Alex Finley, MS, CGC
